LUS012upadacitinibmesalazine
… window (>300x based on 14-day non-GLP tox studies).Conclusions LUS012, a highly selective Kv1.3 inhibitor with gut-restricted exposur…
1articles mentioning drugs
12drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: LUS012 ×
LUS012
This drug is selected. Its supporting articles are shown below.